(AOF) – American stock markets closed without a clear direction during the last session of the week. Investors will learn the Fed’s monetary policy decision on December 17 and 18, which should result in a further rate cut. On the stock side, Broadcom exceeded the $1,000 billion mark in market capitalization during the session, after a strong fourth quarter and strong demand for its AI-related products. The Dow Jones fell 0.20% to 43,828 points while the Nasdaq rose 0.12% to 19,926 points.
The biggest increase in the S&P 500 index – and by a long way – Broadcom soared 24.43% to $224.80 to weigh nearly $1,050 billion on the stock market. The semiconductor and software specialist joins the very exclusive club – including Apple, Nvidia, Microsoft, Meta, Tesla and Alphabet – of companies with more than 1,000 billion capitalization. The technology group benefits from strong demand for its products linked to artificial intelligence and very favorable prospects in this area.
Today’s economic figures
On a monthly basis, import prices increased by 0.1% in the United States in November while they were expected to fall by 0.2%. They were up 0.1% in October.
Values to follow today
Boeing
Boeing has announced plans to expand its operations in Charleston County, South Carolina. The aircraft manufacturer plans to invest $1 billion in infrastructure upgrades at its current site and create 500 new jobs over the next five years. For more than ten years, Boeing South Carolina (BSC) has provided the full production cycle of the 787 Dreamliner. The group manufactures, assembles and delivers 787-8, 787-9 and 787-10 aircraft to customers around the world.
Costco
The Costco store chain revealed quarterly revenue of $62.15 billion that exceeded analysts’ expectations. Its EPS stood at $4.04 for its first financial quarter (ended November 24), compared to $3.58 over the same period last year and a consensus of $3.79. Its net sales over the period increased by 7.5% to $62.15 billion in published data, exceeding the consensus: $62.08 billion.
Gilead
Gilead Sciences is expected to rise in pre-market on Wall Street after announcing that Dietmar Berger, medical director of Sanofi since 2020, will join its teams on January 2, 2025, as medical director, member of the group’s management team . Dr. Berger will succeed Merdad Parsey who has been in the role since 2019: he will assume responsibility for Gilead’s virology, oncology and inflammatory diseases portfolio and oversee the company’s global development and medical affairs.
Novavax
Novavax is expected to rise in pre-market trading on Wall Street after its partnership with Sanofi resulted in an initial milestone payment of $50 million. The biotech emphasizes that its anti-Covid-19 vaccine is included in Sanofi’s two combined vaccine candidates for the prevention of influenza and Covid-19, for which clinical trials have been launched and Fast Track designation recently granted to States. -United.
